Fletcher, C. & Peto, R. The natural history of chronic airflow obstruction. BMJ 1, 1645–1648 (1977).
Lange, P., Celli, B. & Agustí, A. Lung-function trajectories and chronic obstructive pulmonary disease. N. Engl. J. Med. 373, 1575 (2015).
Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128 (2012).
Salvi, S.S. & Barnes, P.J. Chronic obstructive pulmonary disease in non-smokers. Lancet 374, 733–743 (2009).
Melén, E. Bridging genetics, epidemiology, and respiratory medicine. Am. J. Respir. Crit. Care Med. 190, 716–718 (2014).
Svanes, C. et al. Early life origins of chronic obstructive pulmonary disease. Thorax 65, 14–20 (2010).
Celli, B.R. et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur. Respir. J. 45, 879–905 (2015).
Pillai, S.G. et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 5, e1000421 (2009).
Cho, M.H. et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat. Genet. 42, 200–202 (2010).
Cho, M.H. et al. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir. Med. 2, 214–225 (2014).
Hancock, D.B. et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat. Genet. 42, 45–52 (2010).
Loth, D.W. et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat. Genet. 46, 669–677 (2014).
Repapi, E. et al. Genome-wide association study identifies five loci associated with lung function. Nat. Genet. 42, 36–44 (2010).
Soler Artigas, M. et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat. Genet. 43, 1082–1090 (2011).
Soler Artigas, M. et al. Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation. Nat. Commun. 6, 8658 (2015).
Wain, L.V. et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir. Med. 3, 769–781 (2015).
Nelson, M.R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856–860 (2015).
Sanseau, P. et al. Use of genome-wide association studies for drug repositioning. Nat. Biotechnol. 30, 317–320 (2012).
Palmer, L.J. et al. Familial aggregation and heritability of adult lung function: results from the Busselton Health Study. Eur. Respir. J. 17, 696–702 (2001).
Wilk, J.B. et al. Evidence for major genes influencing pulmonary function in the NHLBI family heart study. Genet. Epidemiol. 19, 81–94 (2000).
Weiss, S.T. Lung function and airway diseases. Nat. Genet. 42, 14–16 (2010).
Gudbjartsson, D.F. et al. Large-scale whole-genome sequencing of the Icelandic population. Nat. Genet. 47, 435–444 (2015).
Hao, K. et al. Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet. 8, e1003029 (2012).
Lamontagne, M. et al. Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls. PLoS One 8, e70220 (2013).
Obeidat, M. et al. GSTCD and INTS12 regulation and expression in the human lung. PLoS One 8, e74630 (2013).
Regan, E.A. et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 7, 32–43 (2010).
Vestbo, J. et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur. Respir. J. 31, 869–873 (2008).
Fishman, A. et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N. Engl. J. Med. 348, 2059–2073 (2003).
Bell, B., Rose, C.L. & Damon, H. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Aging Hum. Dev. 3, 5–17 (1972).
Dewey, F.E. et al. Inactivating variants in ANGPTL4 and risk of coronary artery disease. N. Engl. J. Med. 374, 1123–1133 (2016).
Szklarczyk, D. et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447–D452 (2015).
Wilk, J.B. et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am. J. Respir. Crit. Care Med. 186, 622–632 (2012).
Jiang, Z. et al. A chronic obstructive pulmonary disease susceptibility gene, FAM13A, regulates protein stability of β-catenin. Am. J. Respir. Crit. Care Med. 194, 185–197 (2016).
Obeidat, M. et al. Molecular mechanisms underlying variations in lung function: a systems genetics analysis. Lancet Respir. Med. 3, 782–795 (2015).
Carter, R.I., Ungurs, M.J., Mumford, R.A. & Stockley, R.A. Aα-Val360: a marker of neutrophil elastase and COPD disease activity. Eur. Respir. J. 41, 31–38 (2013).
Sand, J.M. et al. Accelerated extracellular matrix turnover during exacerbations of COPD. Respir. Res. 16, 69 (2015).
Jhingran, A. et al. Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection. PLoS Pathog. 11, e1004589 (2015).
Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
Cogan, J.D. et al. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am. J. Respir. Crit. Care Med. 191, 646–655 (2015).
Todd, J.A., Bell, J.I. & McDevitt, H.O. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599–604 (1987).
Hobbs, B.D. et al. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat. Genet. http://dx.doi.org/10.0138/ng.3752 (2017).
Soler Artigas, M. et al. Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am. J. Respir. Crit. Care Med. 184, 786–795 (2011).
Poole, C. A history of the population attributable fraction and related measures. Ann. Epidemiol. 25, 147–154 (2015).
Fadista, J., Manning, A.K., Florez, J.C. & Groop, L. The (in)famous GWAS P-value threshold revisited and updated for low-frequency variants. Eur. J. Hum. Genet. 24, 1202–1205 (2016).
Miller, M.R. et al. Standardisation of spirometry. Eur. Respir. J. 26, 319–338 (2005).
Abecasis, G.R. et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061–1073 (2010).
Huang, J. et al. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nat. Commun. 6, 8111 (2015).
Walter, K. et al. The UK10K project identifies rare variants in health and disease. Nature 526, 82–90 (2015).
Wilk, J.B. et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet. 5, e1000429 (2009).
Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369–375 (2012).
Dastani, Z. et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 8, e1002607 (2012).
Wakefield, J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am. J. Hum. Genet. 81, 208–227 (2007).
van de Bunt, M., Cortes, A., Brown, M.A., Morris, A.P. & McCarthy, M.I. Evaluating the performance of fine-mapping strategies at common variant GWAS loci. PLoS Genet. 11, e1005535 (2015).
Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS One 8, e64683 (2013).
Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP–trait associations. Nucleic Acids Res. 42, D1001–D1006 (2014).
Eicher, J.D. et al. GRASP v2.0: an update on the Genome-Wide Repository of Associations between SNPs and phenotypes. Nucleic Acids Res. 43, D799–D804 (2015).
Higgins, J.P., Thompson, S.G., Deeks, J.J. & Altman, D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 327, 557–560 (2003).
Westra, H.J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238–1243 (2013).
GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).
Kamburov, A., Stelzl, U., Lehrach, H. & Herwig, R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res. 41, D793–D800 (2013).
Segrè, A.V., Groop, L., Mootha, V.K., Daly, M.J. & Altshuler, D. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 6, e1001058 (2010).
Trynka, G. et al. Disentangling the Effects of Colocalizing Genomic Annotations to Functionally Prioritize Non-coding Variants within Complex-Trait Loci. Am. J. Hum. Genet. 97, 139–152 (2015).